- R & D
Clonit has dedicated since the beginning many resources to develop new molecular diagnostic tools in the field of infectious diseases, genetic disorders and molecular oncology markers. The company is involved in different research projects cooperating with public and private institutions and research centers.
Founded in 1987, Clonit srl was one of the first Italian companies operating in the field of biotechnology. Since from the beginning the company has worked to develope innovative and reliable analytical methods in the field of In Vitro diagnostics using molecular biology techinques.
The systems are useful for human diagnostic with particular attention to the detection of viral, bacteria and protozoa infections, genetic mutations and oncological diseases.
The scientific innovations were transferred into ready to use diagnostic kits that, for the operating user-friendliness and the quality, are optimal for routine diagnostic laboratories.
Proprietary technology is covered by a number of International patents some of which have been higly innovative for the field, such as the invention related to a solid state PCR amplification mix using thermoregulated polymers. The standardization of internal quality control system and cross-checks in outer reference labs have made Clonit able to assure the highest standards of care and quality (ISO 9001:2008 and ISO13485:2004 Certified).
The company is registered and authorized from the Italian Ministry of the Health for the production of Medical Diagnostic devices Clonit offers to its customers an unrivalled experience in molecular biology.